Key facts
- This page summarizes Mohan Bala's Form 3 filing for Mersana Therapeutics, Inc. (MRSN).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 07 Sep 2023, 17:46.
Mohan Bala - 05 Sep 2023 Form 3 Insider Report for Mersana Therapeutics, Inc. (MRSN)
- Reporting relationship
- SVP, Chief Development Officer
- Issuer ticker
- MRSN
- Reported as of
- 05 Sep 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Sep 2023, 17:46:47 UTC
- Next SEC filing
- 27 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alejandra Carvajal, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mohan Bala filed Form 3 for Mersana Therapeutics, Inc. (MRSN) on 07 Sep 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRSN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,395
- Date
- 05 Sep 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRSN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 112,500
- Exercise price
- $8.63
- Footnotes
- F1
MRSN
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 157,500
- Exercise price
- $6.06
- Footnotes
- F2
MRSN
holding
Derivative
Restricted stock unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,750
- Exercise price
- $0.000000
- Footnotes
- F3, F4
MRSN
holding
Derivative
Restricted stock unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,000
- Exercise price
- $0.000000
- Footnotes
- F4, F5
MRSN
holding
Derivative
Restricted stock unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 05 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $0.000000
- Footnotes
- F4, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
25% of the shares underlying the option vested on October 25, 2022, and the remainder vested or will vest in equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer on such vesting date.
Footnote F2
The shares underlying the option vested or will vest in equal quarterly installments over four years following the date of grant, January 13, 2023, subject to the Reporting Person's continued service to the Issuer on such vesting date.
Footnote F3
The restricted stock units ("RSUs") will vest in three equal installments on October 25, 2023, October 25, 2024, and October 25, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date.
Footnote F4
Each RSU represents the contingent right to receive one share of common stock of the Issuer.
Footnote F5
The RSUs will vest in equal annual installments over four years following the date of grant, January 13, 2023, subject to the Reporting Person's continued service to the Issuer on such vesting date.
Footnote F6
The RSUs will vest on October 1, 2024, subject to the Reporting Person's continued service to the Issuer on such vesting date.
SEC remarks
Exhibit 24 - Power of Attorney